Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?

Lehlogonolo N.F. Maphalle, Bozena B. Michniak-Kohn, Modupe O. Ogunrombi, Oluwatoyin A. Adeleke*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

15 Citations (Scopus)


Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and long-lasting solutions as TB is one of the top ten causes of ill health and death in children as well as adolescents universally. Minors are particularly susceptible to this severe illness that can be fatal post-infection or even serve as reservoirs for future disease outbreaks. However, pediatric TB is the least prioritized in most health programs and optimal infection/disease control has been quite neglected for this specialized patient category, as most scientific and clinical research efforts focus on developing novel management strategies for adults. Moreover, the ongoing coronavirus pandemic has meaningfully hindered the gains and progress achieved with TB prophylaxis, therapy, diagnosis, and global eradication goals for all affected persons of varying age bands. Thus, the opening of novel research activities and opportunities that can provide more insight and create new knowledge specifically geared towards managing TB disease in this specialized group will significantly improve their well-being and longevity.

Original languageEnglish
Article number1120
Issue number8
Publication statusPublished - Aug 2022


  • COVID-19
  • coronavirus pandemic
  • diagnosis
  • extrapulmonary tuberculosis
  • pediatrics
  • prevention
  • pulmonary tuberculosis
  • treatment


Dive into the research topics of 'Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?'. Together they form a unique fingerprint.

Cite this